Genetic testing: An economic and contractarian analysis

Citations

Cited by:

1. Renaud Bourlès, 2017. "Prevention incentives in long‐term insurance contracts," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 26(3), pages 661-674, September.
   • Renaud Bourlès, 2008. "Moral Hazard In Dynamic Insurance Classification Risk And Prepayment," Working Papers halshs-00340830, HAL.
   • Renaud Bourlès, 2015. "Prevention Incentives in Long-Term Insurance Contracts," AMSE Working Papers 1541, Aix-Marseille School of Economics, France, revised Oct 2015.
   • Renaud Bourlès, 2017. "Prevention incentives in long-term insurance contracts," Post-Print hal-01589993, HAL.
   • Renaud Bourlès, 2015. "Prevention Incentives in Long-Term Insurance Contracts," Working Papers halshs-01214592, HAL.
   • Renaud Bourlès, 2010. "The incentive for prevention in public health Systems," IDEP Working Papers 1001, Institut d'economie publique (IDEP), Marseille, France, revised 17 Feb 2010.
2. Dionne, G. & Doherty, N., 1991. "Adverse Selection In Insurance Markets: A Selective Survey," Cahiers de recherche 9105, Centre interuniversitaire de recherche en économie quantitative, CIREQ.
   • Dionne, G. & Doherty, N., 1991. "Adverse Selection in Insurance Markets: a Selective Survey," Cahiers de recherche 9105, Universite de Montreal, Departement de sciences economiques.
3. Hall, Jane, 1996. "Consumer utility, social welfare, and genetic testing. A response to "Genetic testing: an economic and contractarian analysis"," Journal of Health Economics, Elsevier, vol. 15(3), pages 377-380, June.
4. Francesca Barigozzi & Dominique Henriet, 2006. "Endogenous Information and Self-Insurance in Insurance Markets : a Welfare Analysis," Working Papers halshs-00411337, HAL.
5. Simeon Schudy & Verena Utikal, 2015. "Does imperfect data privacy stop people from collecting personal health data?," TWI Research Paper Series 98, Thurgauer Wirtschaftsinstitut, Universität Konstanz.
6. Bardey, David & De Donder, Philippe, 2013. "Genetic testing with primary prevention and moral hazard," Journal of Health Economics, Elsevier, vol. 32(5), pages 768-779.
   • David Bardey & Philippe De Donder, 2011. "Genetic testing with primary prevention and moral hazard," Documentos de Trabajo 9083, Universidad del Rosario.
   • Bardey, David & De Donder, Philippe, 2012. "Genetic testing with primary prevention and moral hazard," TSE Working Papers 12-320, Toulouse School of Economics (TSE).
   • Bardey, David & De Donder, Philippe, 2012. "Genetic testing with primary prevention and moral hazard," IDEI Working Papers 729, Institut d'Économie Industrielle (IDEI), Toulouse.
   • De Donder, Philippe & Bardey, David, 2012. "Genetic testing with primary prevention and moral hazard," CEPR Discussion Papers 8977, C.E.P.R. Discussion Papers.
   • David Bardey & Philippe De Donder, 2012. "Genetic testing with primary prevention and moral hazard," Documentos CEDE 9798, Universidad de los Andes, Facultad de Economía, CEDE.
7. Emons Winand, 2009. "Genetic Tests and Inter-Temporal Screening in Competitive Insurance Markets," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 9(1), pages 1-19, July.
   • Winand Emons, 2006. "Genetic Tests and Intertemporal Screening in Competitive Insurance Markets," Diskussionsschriften dp0605, Universitaet Bern, Departement Volkswirtschaft.
   • Emons, Winand, 2007. "Genetic Tests and Intertemporal Screening in Competitive Insurance Markets," CEPR Discussion Papers 6047, C.E.P.R. Discussion Papers.
8. Simeon Schudy & Verena Utikal, 2018. "Does Imperfect Data Privacy Stop People from Collecting Personal Data?," Games, MDPI, vol. 9(1), pages 1-23, March.
9. Filipova-Neumann, Lilia & Hoy, Michael, 2014. "Managing genetic tests, surveillance, and preventive medicine under a public health insurance system," Journal of Health Economics, Elsevier, vol. 34(C), pages 31-41.
10. Georges Dionne & Casey Rothschild, 2014. "Economic Effects of Risk Classification Bans," The Geneva Risk and Insurance Review, Palgrave Macmillan;International Association for the Study of Insurance Economics (The Geneva Association), vol. 39(2), pages 184-221, September.
    • Georges Dionne & Casey G. Rothschild, 2014. "Economic Effects of Risk Classification Bans," Cahiers de recherche 1420, CIRPEE.
    • Dionne, Georges & Rothschild, Casey, 2014. "Economic Effects of Risk Classification Bans," Working Papers 14-4, HEC Montreal, Canada Research Chair in Risk Management.
11. Michael Lee Ganz, 2001. "Family health effects: complements or substitutes," Health Economics, John Wiley & Sons, Ltd., vol. 10(8), pages 699-714, December.
12. Ronald Wintrobe, 2002. "Slobodan Milosevic and the Fire of Nationalism," World Economics, World Economics, 1 Ivory Square, Plantation Wharf, London, United Kingdom, SW11 3UE, vol. 3(3), pages 1-26, July.
    • Ronald Wintrobe, 1999. "Slobodan Milosevic and the Fire of Nationalism," University of Western Ontario, Departmental Research Report Series 9911, University of Western Ontario, Department of Economics.
13. Amalia R. Miller & Catherine Tucker, 2018. "Privacy Protection, Personalized Medicine, and Genetic Testing," Management Science, INFORMS, vol. 64(10), pages 4648-4668, October.
14. Hoel, Michael & Iversen, Tor, 2009. "Impact of the public/private mix of health insurance on genetic testing," HERO Online Working Paper Series 1999:1, University of Oslo, Health Economics Research Programme.
15. Bolin, Kristian & Jacobson, Lena & Lindgren, Bjorn, 2002. "Employer investments in employee health: Implications for the family as health producer," Journal of Health Economics, Elsevier, vol. 21(4), pages 563-583, July.
16. Holm, Hakan J., 1997. "Genetic information and investment in human capital," Journal of Health Economics, Elsevier, vol. 16(4), pages 435-452, August.
17. Michael Hoy & Michael Ruse, 2005. "Regulating Genetic Information in Insurance Markets," Risk Management and Insurance Review, American Risk and Insurance Association, vol. 8(2), pages 211-237, September.
18. Richard Peter & Andreas Richter & Petra Steinorth, 2016. "Yes, No, Perhaps? Premium Risk and Guaranteed Renewable Insurance Contracts With Heterogeneous Incomplete Private Information," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 83(2), pages 363-385, June.
19. Michael Hoy & Richard Peter & Andreas Richter, 2014. "Take-up for genetic tests and ambiguity," Journal of Risk and Uncertainty, Springer, vol. 48(2), pages 111-133, April.
20. Karlsson Linnér, Richard & Koellinger, Philipp D., 2022. "Genetic risk scores in life insurance underwriting," Journal of Health Economics, Elsevier, vol. 81(C).
21. Francesca Barigozzi & Dominique Henriet, 2011. "Genetic Information: Comparing Alternative Regulatory Approaches When Prevention Matters," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 13(1), pages 23-46, February.
    • Francesca Barigozzi & Dominique Henriet, 2008. "Genetic Information: Comparing Alternative Regulatory Approaches when Prevention Matters," CHILD Working Papers wp01_09, CHILD - Centre for Household, Income, Labour and Demographic economics - ITALY.
    • F. Barigozzi & D. Henriet, 2009. "Genetic Information: Comparing Alternative Regulatory Approaches when Prevention Matters," Working Papers 657, Dipartimento Scienze Economiche, Universita' di Bologna.
22. Vicky Barham & Rose Anne Devlin & Olga Milliken, 2016. "Genetic Health Risks: The Case for Universal Public Health Insurance," Working Papers 1605E, University of Ottawa, Department of Economics.
23. Strohmenger, R. & Wambach, A., 2000. "Adverse selection and categorical discrimination in the health insurance markets: the effects of genetic tests," Journal of Health Economics, Elsevier, vol. 19(2), pages 197-218, March.
24. Peter, Richard & Richter, Andreas & Thistle, Paul, 2017. "Endogenous information, adverse selection, and prevention: Implications for genetic testing policy," Journal of Health Economics, Elsevier, vol. 55(C), pages 95-107.
25. Christine Arentz, 2012. "Auswirkungen von Gentests in der Krankenversicherung," Otto-Wolff-Institut Discussion Paper Series 04/2012, Otto-Wolff-Institut für Wirtschaftsordnung, Köln, Deutschland.
26. Simeon Schudy & Verena Utikal, 2012. "The Influence of (Im)perfect Data Privacy on the Acquisition of Personal Health Data," Working Paper Series of the Department of Economics, University of Konstanz 2012-12, Department of Economics, University of Konstanz.
    • Simeon Schudy & Verena Utikal, 2012. "The Influence of (Im)perfect Data Privacy on the Acquisition of Personal Health Data," TWI Research Paper Series 76, Thurgauer Wirtschaftsinstitut, Universität Konstanz.
27. Hoel, Michael & Iversen, Tor, 2002. "Genetic testing when there is a mix of compulsory and voluntary health insurance," Journal of Health Economics, Elsevier, vol. 21(2), pages 253-270, March.
    • Michael Hoel & Tor Iversen, 2001. "Genetic Testing When There is a Mix of Compulsory and Voluntary Health Insurance," CESifo Working Paper Series 495, CESifo.
28. Michael Hoy & Peter Lambert, 2000. "Genetic Screening and Price Discrimination in Insurance Markets," The Geneva Risk and Insurance Review, Palgrave Macmillan;International Association for the Study of Insurance Economics (The Geneva Association), vol. 25(2), pages 103-130, December.
    • Michael Hoy & Peter Lambert, "undated". "Genetic Screening and Price Discrimination in Insurance Markets," Discussion Papers 99/25, Department of Economics, University of York.
29. Ray Rees & Patricia Apps, 2006. "Genetic testing, income distribution and insurance markets, CHERE Working Paper 2006/3," Working Papers 2006/3, CHERE, University of Technology, Sydney.
30. Dionne, Georges & Fombaron, Nathalie & Doherty, Neil, 2012. "Adverse selection in insurance contracting," Working Papers 12-8, HEC Montreal, Canada Research Chair in Risk Management.
    • Georges Dionne & Nathalie Fombaron & Neil Doherty, 2012. "Adverse Selection in Insurance Contracting," Cahiers de recherche 1231, CIRPEE.
31. Christine Arentz & Johann Eekhoff & Susanna Kochskämper, 2012. "Private health insurance: a role model for European health systems," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(5), pages 615-621, October.
32. Deborah Wilson, 2005. "Acquisition and disclosure of genetic information under alternative policy regimes," The Centre for Market and Public Organisation 05/118, The Centre for Market and Public Organisation, University of Bristol, UK.
33. Tabarrok, Alexander, 1996. "Genetic testing and human welfare: reply to Hall," Journal of Health Economics, Elsevier, vol. 15(3), pages 381-384, June.
34. Doherty, Neil A. & Thistle, Paul D., 1996. "Adverse selection with endogenous information in insurance markets," Journal of Public Economics, Elsevier, vol. 63(1), pages 83-102, December.